Literature DB >> 1008085

Lupus anticoagulant in myelofibrosis.

B Bernhardt, M Valletta.   

Abstract

A patient with myelofibrosis who also demonstrates a lupus anticoagulant is reported. The presence of a circulating anticoagulant adds to the list of potential hemorrhagic diatheses in myelofibrosis and also demonstrates myelofibrosis to involve a system that may be separate from the myeloid elements of the bone marrow.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1008085     DOI： 10.1097/00000441-197609000-00016

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  4 in total

Review 1.  An immune dysregulation in MPN.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

2.  Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias.

Authors:  R M Pereira; E R Velloso; Y Menezes; S Gualandro; J Vassalo; N H Yoshinari
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Myelofibrosis: Review of clinical and pathological features in fourteen dogs.

Authors:  B Hoff; J H Lumsden; V E Valli; S A Kruth
Journal:  Can Vet J       Date:  1991-06       Impact factor: 1.008

4.  Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.

Authors:  Jen C Wang; Hemant Sindhu; Chi Chen; Ajay Kundra; Muhammad I Kafeel; Ching Wong; Stephen Lichter
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.